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To evaluate the importance of proteolytic activity in the pathogenesis of cell injury by Rickettsia
rickettsii, a series of four aromatic amidine inhibitors of trypsin-like proteases were introduced into the
plaque model. The compounds were shown to be active toward plaque reduction with their order of
effectiveness parallel to their antitrypsin activity. One of the compounds, bis(5-amidino-2-benzimidazolyl)-
methane, at a concentration of 10- M demonstrated complete inhibition of plaque formation on day 6.
Bis(5-amidino-2-benzimidazolyl)methane at the same concentration reduced cell injury even when added to
the system after 72 h of rickettsial infection. The reduction in morbidity in guinea pigs experimentally
infected with R. rickettsii and treated with bis(5-amidino-2-benzimidazolyl)methane as compared with
morbidity in infected, untreated animals, comprised delay in the onset of fever and slightly fewer febrile
animals. Because bis(5-amidino-2-benzimidazolyl)methane had no effect on phospholipase A2, the enzyme
activity associated with penetration-induced cell injury, it is likely that a trypsin-like protease also plays an
essential role either in the physiology of R. rickettsii or as its pathogenic mechanism.
Virions of several different genera require exposure to
proteolytic enzymes to achieve full expression of their
biological properties (7). As a corollary to this fact, protease
inhibitors can be expected to have potential antiviral activi-
ty. This was substantiated by our recent discovery of the
ability of synthetic low-molecular-weight inhibitors of tryp-
sin-like proteases to block respiratory syncytial virus-in-
duced cytopathology (2-4, 10). Although the site of action of
these agents has not yet been determined, we presented
strong evidence that their antiviral effect may be linked to
their antiproteolytic properties. The most potent of the
inhibitory agents, bis(5-amidino-2-benzimidazolyl)methane
(BABIM), was shown to exert the following effects: (i) delay
of penetration of virus into cells, (ii) blockage of virus-
induced cell fusion, (iii) reduction of multiple-cycle yields of
virus, and (iv) reduction in pathology and virus yield in
experimentally infected animals.
Similar to viral diseases, rickettsial infection of cells
involves a penetration step. This event is known to be
enzyme mediated, but thus far only phospholipase A2, and
not a protease, has been shown to participate in the process
(15, 23). Our experience with respiratory syncytial virus
suggested application of the amidine inhibitors to the rickett-
sial system in search of evidence of proteolysis in the
pathogenetic sequence. Such evidence was readily found in
a study of the rickettsial plaque assay, and the results are the
subject of this communication.
MATERIALS AND METHODS
Rickettsiae. Stocks of R. rickettsii (Sheila Smith strain)
were cultivated by inoculation of the yolk sac of 5-day-old
specific pathogen-free embryonated hen eggs (SPAFAS,
Norwich, Conn.) with plaque-purified organisms provided
by Charles L. Wisseman, Jr. (University of Maryland,
Baltimore). Inoculated eggs were incubated at 35°C, and
their yolk sacs were harvested 5 days after inoculation, 24 to
* Corresponding author.
48 h after the death of the chick embryos. Yolk sacs
containing rickettsiae were homogenized in a Waring blend-
er, diluted in sucrose phosphate glutamate (0.218 M sucrose,
0.0038 M KH2PO4, 0.0072 M K2HPO4, 0.0049 M glutamate,
pH 7.0) (1) to a 1% suspension, and stored frozen at -70°C in
1-ml samples. Samples were titrated by plaque assay in chick
embryo cell culture and found to contain 7 x 105 PFU/ml.
Plaque model. Flasks (Corning Glass Works, Corning,
N.Y.) with 25-cm2 monolayers of E6 clone Vero (African
green monkey kidney) cells were inoculated with 0.1 ml of a
suspension of R. rickettsii diluted 10-3 in brain heart infusion
broth. The inoculum was adsorbed for 30 min before the
addition of 5 ml of minimal essential medium (GIBCO
Laboratories, Grand Island, N.Y.) containing 5% fetal bo-
vine serum (Flow Laboratories, Inc., McLean, Va.), 0.02 M
HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic
acid) buffer, 2 mM L-glutamine, ca. 0.075% NaHCO3 to final
pH 7.3, 0.5% agarose (Sea Kem, FMC Corp., Marine
Colloids Div., Rockland, Maine), and different concentra-
tions of protease inhibitors. Flasks were incubated at 35°C
for 4 days at which time 5 ml of an identical second overlay
medium containing 0.01% neutral red was added. After
further incubation, plaques were counted on various combi-
nations of days 5, 6, and 7 (14, 16, 20-22).
Protease inhibitors. Inhibitors of trypsin-like proteases
used in these experiments were BABIM, 1,2-bis(5-amidino-
2-benzimidazolyl)ethane, 1,5-bis(5-amidino-2-benzimidazo-
lyl)pentane, and 5-amidinoindole. They were synthesized as
previously reported (5, 9).
Experimental design. Each of these aromatic amidines was
incorporated into both the first and second overlay media of
three flasks at concentrations of 10-4, 10', and 10-6 M, and
plaque counts were compared with those of monolayers
inoculated with the same rickettsial suspension and overlaid
with medium containing no protease inhibitors. Control
flasks included uninoculated, untreated monolayers and also
uninfected monolayers treated with a 10-4 M concentration
of the aromatic amidines for evaluation of toxicity. The
mean plaque count was calculated for each concentration of
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TABLE 1. Effect of inhibitors of trypsin-like proteases on formation of plaques with Rickettsia rickettsii
Effect of inhibitors on daya:
Compound Concn (M) 5 6 7 T (psMn
Plaques Size Plaques Size Plaques Size
Bis(5-amidino-2-benzimidazolyl)- 10-4 0 ±0 0 0 ± 0 0 0.017
methane 10-5 - 0±0 0 15.0 3.5 S
10-6 46.0 1.5 S 52.0 1.2 S
None 70.0 5.0 N 68.5 5.5 N
1,2-Bis(5-amidino-2-benzinidazolyl)- 10-4 Toxic Toxic Toxic 4.68
ethane 10-5 21.7 ± 3.7 N 23.7 ± 3.8 N 23.0 ± 5.0 N
10-6 22.3 ± 5.8 N 29.0 ± 7.6 N 31.7 ± 9.4 N
None 32.0 ± 3.0 N 37.3 ± 3.2 N 38.0 ± 2.6 N
1,5-Bis(amidino-2-benzimidozolyl)- 10-4 0 ± 0 0 9.46
pentane 10-5 60.7 ± 5.2 S - -
10-6 67.3 ± 2.4 N
None 71.0 ± 0.8 N
5-Amidinoindole 10-4 34.7 ± 2.0 N 51.7 ± 0.9 N 29.1
1o-5 42.7 ± 1.2 N 56.7 ± 1.7 N -
10-6 Contam. Contam.
None 39.5 ± 5.5 N 58.0 ± 6.0 N
a Plaques are measured by mean number of plaques per flask ± standard error of the mean and by size: , not exanmined; 0, no plaques; S,
small plaques; N, normal-size plaques; Contam., culture contaminated.
each amidine and was compared with the count of the R.
rickettsii-infected flasks containing no amidine.
In a second experiment, the first overlay after inoculation
of the monolayer with R. rickettsii contained no aromatic
amidines. On day 3 (72 h after inoculation of rickettsiae), a
second overlay was added to each flask. The second overlay
contained BABIM at concentrations of 2 x 10-4, 2 x 10
and 2 x 10-6 M to achieve final protease inhibitor concentra-
tions of 10-4, 10-5, and 10-6 M in the combined overlay
medium.
Guinea pig experiment. Twenty-five adult (400- to 600-g)
male guinea pigs (Hartley strain) were divided as follows.
Ten animals were inoculated intraperitoneally with 330 50%
tissue culture infective doses (ca. 38 50% guinea pig infec-
tious doses) of R. ri'ckettsii (Sheiia Smith strain) and treated
with BABIM at a dose of 15 mg/kg per day given daily by the
intraperitoneal route beginning 30 min after rickettsial inocu-
lation and continuing for 9 days; ten animals were inoculated
intraperitoneally with 330 50% tissue culture infective doses
of R. rickettsii and given no treatment, and five uninfected
animals were given 15 mg of B3ABIM per kg daily via the
intraperitoneal route for 9 days. Animals were examined
daily, and rectal temperatures were measured with a battery-
operated thermometer with a flexible probe (Telethermom-
eter; Yellow Springs Instrument Co., Yellow Springs, Ohio).
Phospholipase A2 assay. The procedure used was that
described by Vigo et al. (12), in which hydrolysis of phos-
pholipid-containing liposomes is followed spectrophotomet-
rically at 340 nm. The assay mixtures of 1 ml of 0.1 M Tris-
hydrochloride buffer (pH 7.2) contained 0.5 mg of
dipalmitoyl-lecithin (as liposomes), 1 mM CaCl2, and 10 U of
phospholipase A2 from Naja naja venom (Sigma Chemical
Co., St. Louis, Mo.). The reaction was terminated by the
addition of 1 ml of methanol containing 15 mM EDTA.
RESULTS
The effects of inhibitors of trypsin-like proteases on
plaque count and size are presented in Table 1. There was a
close correlation between the reduction in plaque count and
the inhibition constants (Ki values) for trypsin (2). The most
marked plaque reduction was observed with the most effec-
tive inhibitor of trypsin activity, BABIM, with no plaques
being observed on day 6 after inoculation in the presence of
10-5 M of the amidine. Measurable plaque reduction was
also observed at a concentration of 10-6 M BABIM, and the
plaques preseht were smaller than untreated plaques. The
least active inhibitor of trypsin, 5-omidinoindole, which has
a Ki of 29.1 ,uM for trypsin (5), showed minimal effects on R.
rickettsii plaque count and size. The monolayers treated with
1,5-bis(5-amidine-2-benzimidazolyl)pentane, having an in-
termediate Ki (9), showed evidence for reduction in cell
injury caused by R. rickettsii as measured by plaque count
and size. However, the effect was less than that of BABIM.
At concentrations of 10-4 M and less, none of the aromatic
amidines except 1,2-bis(5-amidino-2-benzimidazolyl)ethane
caused cytotoxic effect on the Vero cells.
To determine whether delayed exposure to BABIM would
still influence the cytopathic events in the monolayers, a
second series of experiments was carried out. Here, the
Vero cell culture was inoculated with R. rickettsii, and the
establishment of infected foci was allowed to proceed nor-
mally by feeding with an initial overlay free of BABIM. On
day 3 after inoculation, second overlays containing various
concentrations of the inhibitor were added, and the resulting
effects on the monolayer on day 6 and 7 were recorded
(Table 2). As can be seen, there was complete suppression of
plaque formation at a BABIM concentration of 1i0 M. At a
concentration of 10- M, there was still a notable reduction
in plaque count. However, the effect was less pronounced
than it was when BABIM had been present in the medium
immediately after the inoculation (Table 1).
BABIM was somewhat toxic for guinea pigs, causing a
transient fever (.40'C) early in the course of treatment (4 of
5 animals on day 3 and 2 of 5 animals on day 4) (Table 3). A
similar transient fever was observed early in the course of
BABIM treatment of animals infected with R. rickettsii.
However, the temperatures of all guinea pigs returned to
base line before day 5. Onset of fever was delayed; 5 of 10
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TABLE 2. Efect of treating Rickettsia rickettsii plaque model




Plaques Size Plaques Size
10-4 0±0 0 0±0 0
10-5 31.3 ± 5.4 N 50.0 ± 13.0 S
10-6 67.7 ± 9.0 N 82.7 ± 9.5 N
None 76.3 ± 3.8 N 82.0 ± 3.1 N
a Plaques are measured by mean number of plaques per flask ±
standard error of the mean and by size: 0, no plaques; N, normal
plaque size; S, small plaques.
untreated animals had fever on day 5 as compared with no
febrile animals in the BABIM-treated group. On day 6, 8 of
10 untreated animals were febrile as compared with only 2 of
10 BABIM-treated animals. Four febrile animals in each
group died during the course of the rickettsial disease.
BABIM was found to have no effect on the hydrolysis of
dipalmitoyl-lecithin liposomes by phospholipase A2 from
Naja naja venom.
DISCUSSION
The order of effectiveness of aromatic amidines in reduc-
ing plaque formation by R. rickettsii follows their order of
effectiveness in inhibiting trypsin and several other trypsin-
like proteases and corresponds to their order of effectiveness
in blocking cell fusion by respiratory syncytial vit-us in vivo
(2, 5, 10). This parallelism of activities at low concentrations
argues strongly for the antirickettsial effect resulting from
the action of compounds as protease inhibitors on a trypsin-
like enzyme. However, it was also necessary to consider the
possibility that amidines might act by inhibition of phospho-
lipase A2, especially since a cell penetration phospholipase
appears to be an important rickettsia! pathogenic mechanism
and a protease inhibitor of a different structure had previous-
ly been shown to suppress phospholipase A2 activity (8). We
showed this possibility to be unlikely by demonstrating that
BABIM at a concentration of 10-4 M has no effect on
phospholipase A2 activity (from Naja naja venom). Of
course, the linkage of a trypsin-like protease in a chain of
enzymes that includes phospholipase A2 cannot be excluded
(11). In fact, trypsin activation is necessary for all mammali-
an pancreatic phospholipases A2 (13). Some of the other
possible mechanisms by which a trypsin-like protease might
fit into the scheme of rickettsial injury to cells, besides
proteolytic activation of the penetration mechanism-associ-
ated phospholipase, include direct proteolytic attack on the
host cell membrane either during entrance into the cell or on
release from the cell or an essential intracellular catabolic
function.
The reduction of plaque counts by the addition of BABIM
72 h after the establishment of rickettsia-infected foci docu-
ments that the protease inhibitors are not merely preventing
initial rickettsial infection and suggests that protease inhibi-
tors may be blocking a rickettsial function essential to
expression of the pathogenic mechanism. The hypothesis
that a protease-associated pathogenic mechanism is blocked
by BABIM is also supported by the delay of plaque forma-
tion by a 10-5 M concentration of BABIM with delayed
appearance of several small plaques on day 7. Rickettsiae
survived the BABIM treatment and caused formation of a
few plaques, presumably after protease activity overcame
the protease inhibitory activity. Because fatal cases of
Rocky Mountain spotted fever are often diagnosed and
treated too late in the course of disease for rickettsiostatic
antimicrobial agents to prevent the demise of the patients (6,
17-19), additional inhibition of rickettsial injury to the host
would benefit such critically ill patients. Consideration of the
possible use of inhibitors of trypsin-like proteases for the
treatment of rickettsial diseases would require investigation
of these drugs inr other animal models, further study of the
mechanism of action of protease inhibitors on the rickettsia-
host cell interaction, and information on the toxicity of these
compounds in humans, especially on the inflammatory and
coagulation mechanisms: complement, kallikrein, coagula-
tion, and fibrinolysis.
Data on the toxicity of BABIM include the acute 50%
lethal dose for cotton rats of 136 mg of BABIM per kg and a
dosage for cotton rats of 30 mg of BABIM per kg daily for 7
days without ill effects. Current pharmacological studies of
TABLE 3. Effect of BABIM on experimental infection of guinea pigs with Rickettsia rickettsii
No.' of
Rickettsia-infected guinea pigs
Day Uninfected guinea pigs: BABIM treated
BABIM treated No treatment
Afebrile Febrile Dead Afebrile Febrile Dead Afebrile Febrile Dead
1 10 0 0 10 0 0 5 0 0
2 6 4 (40.1) 0 10 0 0 5 0 0
3 2 8(40.2) 0 10 0 0 1 4(40.1) 0
4 6 4 (40.1) 0 10 0 0 3 2 (40.1) 0
5 10 0 0 5 5 (40.6) 0 5 0 0
6 8 2 (40.8) 0 2 8 (40.7) 0 5 0 0
7 6 4 (40.7) 0 2 8 (40.7) 0 5 0 0
8 5 4 (40.7) 1 2 8 (40.7) 0 5 0 0
9 4 5 (40.7) 1 3 7 (40.8) 0 5 0 0
10 6 3 (40.7) 1 2 7 (40.8) 1 5 0 0
11 4 3 (40.5) 3 4 5 (40.7) 1 5 0 0
12 6 1 (40.8) 3 5 3 (40.6) 2 5 0 0
13 6 1 (40.4) 3 4 3 (40.4) 3 5 0 0
14 6 1 (40.4) 3 4 3 (40.3) 3 5 0 0
Final 6 0 4 6 0 4 5 0 0
a The values in parentheses are the mean temperatures of febrile guinea pigs.
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rats that received a dose of 20 mg of BABIM per kg daily and
of mice that received a dose of 20 mg of BABIM per kg daily
have not detected any toxicity. These observations of prote-
ase inhibitors blocking rickettsial injury to cells offer inter-
esting new hypotheses for studying rickettsial pathogenesis.
At this point, they should be used as tools for elucidating
rickettsial physiology and pathogenic mechanisms.
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